Velopharyngeal insufficiency

From WikiMD's Medical Encyclopedia

Revision as of 18:05, 25 February 2024 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Velopharyngeal insufficiency (VPI) is a medical condition where the velopharyngeal sphincter (soft palate muscle in the back of the throat) is unable to close completely during the production of speech sounds, leading to a nasal quality of voice. This condition can be congenital or acquired and is often associated with cleft palate and other craniofacial anomalies.

Causes

The causes of velopharyngeal insufficiency can be divided into two main categories: congenital and acquired. Congenital causes include cleft palate, submucous cleft palate, and other craniofacial anomalies. Acquired causes include adenoidectomy (removal of the adenoids), tonsillectomy (removal of the tonsils), and trauma to the throat or neck.

Symptoms

The main symptom of velopharyngeal insufficiency is a nasal quality of voice, also known as hypernasality. Other symptoms may include difficulty swallowing, nasal regurgitation of food and liquids, and speech articulation problems.

Diagnosis

Diagnosis of velopharyngeal insufficiency is typically made by a speech-language pathologist (SLP) through a combination of perceptual speech assessment, instrumental assessment (such as nasopharyngoscopy or videofluoroscopy), and patient history.

Treatment

Treatment for velopharyngeal insufficiency depends on the cause and severity of the condition. Options may include speech therapy, prosthetic devices, and surgery. The goal of treatment is to improve the function of the velopharyngeal sphincter and reduce symptoms.

See also

This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.